Atlas Trials

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Clinical trial NCT05540340 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05540340
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaLymphoma, B-CellLymphoma, T-CellLymphoma, HodgkinLymphoma, Non-Hodgkin
Start date
2022-09-09
Primary completion
2027-09-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.